SOD2 and breast cancer: Our lab has found that decreased SIRT3 expression, and increased MnSOD acetylation, is correlated with poor clinical prognosis in human breast cancer and specifically associated with luminal B breast tumor malignancies, which share similar tumor characteristics with those of the mammary tumors observed in mice lacking Sirt37, 49.